Ultragenyx Pharmaceutical Inc.

Q4 2021 13F Holders

Symbol
RARE
CUSIP
90400D108
Type
Equity
Class
COM
Num filers
238
Total reported value, excl. options
$5.70B
Manager Report Date Value ($000) Shares